Literature DB >> 26983415

Tobacco use is associated with reduced amplitude and intensity dependence of the cortical auditory evoked N1-P2 component.

Philippe Jawinski1,2,3, Nicole Mauche4,5, Christine Ulke4,6, Jue Huang5, Janek Spada5,6, Cornelia Enzenbach4,7, Christian Sander4,5,6, Ulrich Hegerl4,5,6, Tilman Hensch4,5.   

Abstract

RATIONALE: Tobacco use is linked to cerebral atrophy and reduced cognitive performance in later life. However, smoking-related long-term effects on brain function remain largely uncertain. Previous studies suggest that nicotine affects serotonergic signaling, and the intensity dependence (alias loudness dependence) of the auditory evoked N1-P2 potential has been proposed as a marker of serotonergic neurotransmission.
OBJECTIVE: In the present study, we assesed the effects of chronic smoking on amplitude and intensity dependence of the auditory evoked N1-P2 potential.
METHODS: Subjects underwent a 15-min intensity dependence of auditory evoked potentials (IAEP) paradigm. From N = 1739 eligible subjects (40-79 years), we systematically matched current smokers, ex-smokers, and never-smokers by sex, age, alcohol and caffeine consumption, and socioeconomic status. Between-group differences and potential dose-dependencies were evaluated.
RESULTS: Analyses revealed higher N1-P2 amplitudes and intensity dependencies in never-smokers relative to ex- and current smokers, with ex-smokers exhibiting intermediate intensity dependencies. Moreover, we observed pack years and number of cigarettes consumed per day to be inversely correlated with amplitudes in current smokers.
CONCLUSIONS: According to the IAEP serotonin hypothesis, our results suggest serotonin activity to be highest in current smokers, intermediate in ex-smokers, and lowest in never-smokers. To our knowledge, the present study is the first providing evidence for a dose-dependent reduction in N1-P2 amplitudes. Further, we extend prior research by showing reduced amplitudes and intensity dependencies in ex-smokers even 25 years, on average, after cessation. While we can rule out several smoking-related confounders to bias observed associations, causal inferences remain to be established by future longitudinal studies.

Entities:  

Keywords:  Addiction; Auditory evoked potentials; EEG; Intensity dependence; Loudness dependence; N1-P2; N100; P200; Smoking

Mesh:

Substances:

Year:  2016        PMID: 26983415     DOI: 10.1007/s00213-016-4268-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  59 in total

Review 1.  Misunderstanding analysis of covariance.

Authors:  G A Miller; J P Chapman
Journal:  J Abnorm Psychol       Date:  2001-02

2.  Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: evidence from auditory cortical stimulus processing.

Authors:  J Gallinat; D Kunz; U E Lang; P Kalus; G Juckel; J Eggers; R Mahlberg; M Staedtgen; C Wernicke; H Rommelspacher; M N Smolka
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

3.  Auditory-evoked potentials as indicator of brain serotonergic activity--first evidence in behaving cats.

Authors:  G Juckel; M Molnár; U Hegerl; V Csépe; G Karmos
Journal:  Biol Psychiatry       Date:  1997-06-15       Impact factor: 13.382

Review 4.  Assessment of Wakefulness and Brain Arousal Regulation in Psychiatric Research.

Authors:  Christian Sander; Tilman Hensch; Dirk Alexander Wittekind; Daniel Böttger; Ulrich Hegerl
Journal:  Neuropsychobiology       Date:  2016-02-23       Impact factor: 2.328

Review 5.  Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis.

Authors:  U Hegerl; G Juckel
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

6.  The intensity dependence of the auditory evoked N1 component as a predictor of response to Citalopram treatment in patients with major depression.

Authors:  Thomas Linka; Bernhard W Müller; Stefan Bender; Gudrun Sartory
Journal:  Neurosci Lett       Date:  2004-09-09       Impact factor: 3.046

7.  Smoking and mental illness in the U.S. population.

Authors:  Philip H Smith; Carolyn M Mazure; Sherry A McKee
Journal:  Tob Control       Date:  2014-04-12       Impact factor: 7.552

Review 8.  The burden of smoking-related ill health in the UK.

Authors:  S Allender; R Balakrishnan; P Scarborough; P Webster; M Rayner
Journal:  Tob Control       Date:  2009-06-09       Impact factor: 7.552

9.  Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.

Authors:  G Juckel; P Mavrogiorgou; S Bredemeier; J Gallinat; T Frodl; C Schulz; H-J Möller; U Hegerl
Journal:  Pharmacopsychiatry       Date:  2004-03       Impact factor: 5.788

Review 10.  Neuropathology of cigarette smoking.

Authors:  Raymond Chuen-Chung Chang; Yuen-Shan Ho; Shun Wong; Stephen M Gentleman; Ho-Keung Ng
Journal:  Acta Neuropathol       Date:  2013-11-16       Impact factor: 17.088

View more
  2 in total

1.  Evoked potentials and behavioral performance during different states of brain arousal.

Authors:  Jue Huang; Tilman Hensch; Christine Ulke; Christian Sander; Janek Spada; Philippe Jawinski; Ulrich Hegerl
Journal:  BMC Neurosci       Date:  2017-01-25       Impact factor: 3.288

Review 2.  Biomarkers and neuromodulation techniques in substance use disorders.

Authors:  Bettina Habelt; Mahnaz Arvaneh; Nadine Bernhardt; Ivan Minev
Journal:  Bioelectron Med       Date:  2020-02-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.